Federal health advisers are recommending that a decades-old birth control pill be sold without a prescription.
advisers said Wednesday that a decades-old birth control pill should be sold without a prescription, paving the way for a likely U.S. approval of the first over-the-counter contraceptive medication.
If the FDA follows the nonbinding recommendation, Perrigo's drug, Opill, would become the first contraceptive pill to be moved out from behind the pharmacy counter onto store shelves. Currently, a prescription is required in the U.S. "I do believe this is a viable option to support access and will support the prevention of unintended and unwanted pregnancies," said Jolie Haun, a researcher with the Department of Veterans Affairs, who voted in favor of the pill.
But the panel largely set those concerns aside, emphasizing the benefits of providing more effective birth control, particularly to young people and lower-income groups, than what's available over the counter now, like condoms and diaphragms.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA advisory panels back making Opill birth control pill available over-the-counterJUST IN: FDA advisory panels vote unanimously to recommend making a birth control pill available without a prescription. The FDA is expected to decide in late summer whether to follow the recommendation of the committees.
Lire la suite »
FDA panel backs over-the-counter birth control pill, teeing up approvalBREAKING: An FDA panel voted to back the sale of an over-the-counter birth control pill, clearing the way for approval.
Lire la suite »
FDA advisors recommend sale of birth control pill without a prescriptionFDA scientists raised concerns about whether the general public will understand the drug label and use HRA Pharma's Opill in the right way.
Lire la suite »
FDA may allow birth control pill without prescription this summer as experts weigh dataHRA Pharma asked the Food and Drug Administration to allow over-the-counter sales of Opill after the Supreme Court said there was no federal right to abortion.
Lire la suite »
FDA raises concerns about over-the-counter birth control pillU.S. regulators will vote this week on whether the contraceptive Opill should be made widely available without a prescription.
Lire la suite »
FDA advisory committees meeting to discuss over-the-counter birth controlAdvisory committees of the U.S. Food and Drug Administration are meeting Tuesday and Wednesday to review the first-ever application for an over-the-counter birth control pill.
Lire la suite »